Monday, 10 October 2011 00:00 Last Updated on Wednesday, 12 October 2011 08:18
News - RESEARCH NEWS
CHRONIX BIOMEDICAL AND HEMISPHERX BIOPHARMA JOINTLY FILE PATENT APPLICATION FOR A BLOOD TEST FOR CHRONIC FATIGUE SYNDROME (CFS)
—CHRONIX TECHNOLOGY FOCUSES ON CHANGES TO CFS PATIENTS’ DNA—
— HEMISPHERX AND CHRONIX PLAN STUDIES TO VALIDATE TECHNOLOGY AS A POTENTIAL DIAGNOSTIC TEST FOR CFS —see link